Deutsche Bank AG Buys 47,130 Shares of Elevance Health, Inc. $ELV

Deutsche Bank AG boosted its stake in shares of Elevance Health, Inc. (NYSE:ELV) by 5.6% in the fourth quarter, according to the company in its most recent 13F filing with the Securities & Exchange Commission. The institutional investor owned 889,836 shares of the company’s stock after buying an additional 47,130 shares during the period. Deutsche Bank AG’s holdings in Elevance Health were worth $311,932,000 at the end of the most recent reporting period.

A number of other institutional investors and hedge funds also recently added to or reduced their stakes in the stock. Alteri Wealth LLC bought a new position in Elevance Health during the 4th quarter valued at approximately $223,000. Pettyjohn Wood & White Inc. increased its position in Elevance Health by 2.8% during the 4th quarter. Pettyjohn Wood & White Inc. now owns 4,438 shares of the company’s stock valued at $1,556,000 after buying an additional 119 shares in the last quarter. Focus Partners Advisor Solutions LLC increased its position in Elevance Health by 8.2% during the 4th quarter. Focus Partners Advisor Solutions LLC now owns 3,688 shares of the company’s stock valued at $1,293,000 after buying an additional 278 shares in the last quarter. Commonwealth Retirement Investments LLC bought a new position in Elevance Health during the 4th quarter valued at approximately $146,000. Finally, Waddell & Associates LLC increased its position in Elevance Health by 2.6% during the 4th quarter. Waddell & Associates LLC now owns 1,241 shares of the company’s stock valued at $435,000 after buying an additional 32 shares in the last quarter. Institutional investors own 89.24% of the company’s stock.

Wall Street Analyst Weigh In

A number of research analysts recently weighed in on ELV shares. Guggenheim raised their price objective on Elevance Health from $396.00 to $399.00 and gave the company a “buy” rating in a research report on Friday, April 24th. Weiss Ratings upgraded Elevance Health from a “hold (c-)” rating to a “hold (c)” rating in a research note on Monday, May 18th. Robert W. Baird increased their target price on Elevance Health from $317.00 to $331.00 and gave the company a “neutral” rating in a research note on Thursday, April 23rd. UBS Group increased their target price on Elevance Health from $400.00 to $460.00 and gave the company a “buy” rating in a research note on Friday, May 22nd. Finally, Evercore reiterated a “hold” rating on shares of Elevance Health in a research note on Tuesday, May 19th. Fourteen research analysts have rated the stock with a Buy rating and nine have given a Hold rating to the stock. Based on data from MarketBeat.com, the company currently has a consensus rating of “Moderate Buy” and an average price target of $416.11.

Elevance Health Stock Performance

Shares of ELV opened at $404.33 on Thursday. The business’s fifty day simple moving average is $362.40 and its two-hundred day simple moving average is $343.89. The company has a current ratio of 1.48, a quick ratio of 1.48 and a debt-to-equity ratio of 0.70. Elevance Health, Inc. has a 12 month low of $273.71 and a 12 month high of $426.98. The company has a market cap of $87.81 billion, a price-to-earnings ratio of 17.20, a P/E/G ratio of 2.40 and a beta of 0.67.

Elevance Health (NYSE:ELV) last issued its earnings results on Wednesday, April 22nd. The company reported $12.58 EPS for the quarter, beating the consensus estimate of $10.74 by $1.84. The business had revenue of $49.49 billion for the quarter, compared to the consensus estimate of $48.21 billion. Elevance Health had a return on equity of 15.58% and a net margin of 2.62%.The company’s revenue was up 1.5% compared to the same quarter last year. During the same period last year, the business posted $11.97 EPS. Elevance Health has set its FY 2026 guidance at 19.850- EPS. Research analysts anticipate that Elevance Health, Inc. will post 26.94 earnings per share for the current fiscal year.

Elevance Health Announces Dividend

The company also recently declared a quarterly dividend, which will be paid on Thursday, June 25th. Stockholders of record on Wednesday, June 10th will be paid a $1.72 dividend. This represents a $6.88 dividend on an annualized basis and a dividend yield of 1.7%. The ex-dividend date is Wednesday, June 10th. Elevance Health’s dividend payout ratio (DPR) is 29.26%.

About Elevance Health

Elevance Health, Inc (NYSE: ELV) is a large U.S.-based health benefits company that provides a broad range of health insurance products and related services. Headquartered in Indianapolis, the company rebranded from Anthem, Inc to Elevance Health in 2022 while continuing to operate consumer-facing health plans under established state and national brands. Gail Boudreaux serves as chief executive officer and president, leading the company’s strategic focus on integrated health care and benefit delivery.

Elevance’s core activities include offering medical and specialty health plans for individuals, employers and government programs, including Medicare and Medicaid managed-care products.